The chemokine CXCL12 was particularly dysregulated in skeletal muscle from individuals with type 2 diabetes, and exposure of cultured muscle cells to this exerkine directly triggered signaling events affecting proliferation and differentiation. The gene discussed is CXCL12; the disease is type 2 diabetes mellitus.